×
Adjunctive Armodafinil for Major Depressive Episodes Associated With Bipolar I Disorder: A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Proof-of-Concept Study PDF
$ 40.00
Adjunctive Armodafinil for Major Depressive Episodes Associated With Bipolar I Disorder: A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Proof-of-Concept Study PDF quantity
$ 40.00
×
Association Between DβH 5' ²-Insertion/Deletion Polymorphism and Cognition in Patients With Chronic Schizophrenia PDF
$ 40.00
Association Between DβH 5' ²-Insertion/Deletion Polymorphism and Cognition in Patients With Chronic Schizophrenia PDF quantity
$ 40.00
×
Psychotherapy for Depression in Older Veterans Via Telemedicine: Effect on Quality of Life, Satisfaction, Treatment Credibility, and Service Delivery Perception PDF
$ 40.00
Psychotherapy for Depression in Older Veterans Via Telemedicine: Effect on Quality of Life, Satisfaction, Treatment Credibility, and Service Delivery Perception PDF quantity
$ 40.00
×
ARVCF Genetic Influences on Neurocognitive and Neuroanatomical Intermediate Phenotypes in Chinese Patients With Schizophrenia PDF
$ 40.00
ARVCF Genetic Influences on Neurocognitive and Neuroanatomical Intermediate Phenotypes in Chinese Patients With Schizophrenia PDF quantity
$ 40.00
×
Impact of Deleting 5 DSM-IV Personality Disorders on Prevalence, Comorbidity, and the Association Between Personality Disorder Pathology and Psychosocial Morbidity PDF
$ 40.00
Impact of Deleting 5 DSM-IV Personality Disorders on Prevalence, Comorbidity, and the Association Between Personality Disorder Pathology and Psychosocial Morbidity PDF quantity
$ 40.00
×
Health-Related Quality-of-Life Measure Enhances Acute Treatment Response Prediction in Depressed Inpatients PDF
$ 40.00
Health-Related Quality-of-Life Measure Enhances Acute Treatment Response Prediction in Depressed Inpatients PDF quantity
$ 40.00
×
Efficacy Outcomes From 3 Clinical Trials of Edivoxetine as Adjunctive Treatment for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment PDF
$ 40.00
Efficacy Outcomes From 3 Clinical Trials of Edivoxetine as Adjunctive Treatment for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart